Showing results (231-240 of 291) with videos related to

Sort By:
Pageof 30
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2025
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)Thomas Büttner, Milka Marinova, Florian C Gaertner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonateHolger Palmedo, Agnieska Manka-Waluch, Peter Albers, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivoMaria A Gonzalez-Carmona, Veronika Lukacs-Kornek, Anne Timmerman, et al.
British Journal of Haematology|April 26, 2002
Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiologyMarcus Gorschlüter, Günter Marklein, Katja Höfling, et al.
International Immunology|September 13, 2006
Dendritic cell activating peptides induce distinct cytokine profilesGloria Telusma, Sandip Datta, Ivan Mihajlov, et al.
Medcomm|June 3, 2024
Oncogenes and tumor suppressor genes: functions and roles in cancersTikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study GroupAnja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Pageof 30